Use of oral enzymes to treat carbohydrate intolerance: adjunct therapy to the low FODMAP dietary treatment of irritable bowel syndrome. [ 2013 - 2015 ]

Research Grant

Researchers: Prof Peter Gibson (Principal investigator) ,  Dr Jane Muir ,  Prof Ben Boyd

Brief description Irritable bowel syndrome (IBS) is a common disorder affecting 1 in 7 Australians and fermentation of poorly digested short chain carbohydrates are major dietary triggers. The lack of certain digestive enzymes is a major reason why some carbohydrates are not digested. This project will explore the potential use of oral enzyme supplements to assist with the digestion of these indigestible carbohydrates with the potential for use as adjunct therapy to treat gut symptoms associated with IBS.

Funding Amount $AUD 610,197.06

Funding Scheme Project Grants

Notes Standard Project Grant